{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,1]],"date-time":"2026-10-01T19:49:56Z","timestamp":1790884196865,"version":"4.1.0"},"reference-count":30,"publisher":"Springer Science and Business Media LLC","issue":"9","license":[{"start":{"date-parts":[[2024,8,22]],"date-time":"2024-08-22T00:00:00Z","timestamp":1724284800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2024,8,22]],"date-time":"2024-08-22T00:00:00Z","timestamp":1724284800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"funder":[{"DOI":"10.13039\/501100001691","name":"KAKENHI","doi-asserted-by":"crossref","award":["23K07440"],"award-info":[{"award-number":["23K07440"]}],"id":[{"id":"10.13039\/501100001691","id-type":"DOI","asserted-by":"crossref"}]},{"DOI":"10.13039\/501100001691","name":"KAKENHI","doi-asserted-by":"crossref","award":["22K19530"],"award-info":[{"award-number":["22K19530"]}],"id":[{"id":"10.13039\/501100001691","id-type":"DOI","asserted-by":"crossref"}]},{"DOI":"10.13039\/501100004820","name":"Mochida Pharmaceutical Company","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100004820","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["J Mol Med"],"published-print":{"date-parts":[[2024,9]]},"DOI":"10.1007\/s00109-024-02474-0","type":"journal-article","created":{"date-parts":[[2024,8,23]],"date-time":"2024-08-23T08:02:39Z","timestamp":1724400159000},"page":"1175-1186","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":2,"title":["Protective role of M3 muscarinic acetylcholine receptor in indomethacin-induced small intestinal injury"],"prefix":"10.1007","volume":"102","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-8553-5084","authenticated-orcid":false,"given":"Yoko","family":"Igarashi-Hisayoshi","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Eikichi","family":"Ihara","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiaopeng","family":"Bai","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yoshimasa","family":"Tanaka","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Haruei","family":"Ogino","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Takatoshi","family":"Chinen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yasushi","family":"Taguchi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yoshihiro","family":"Ogawa","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2024,8,22]]},"reference":[{"key":"2474_CR1","doi-asserted-by":"publisher","first-page":"879","DOI":"10.1007\/s00535-009-0102-2","volume":"44","author":"K Higuchi","year":"2009","unstructured":"Higuchi K, Umegaki E, Watanabe T et al (2009) Present status and strategy of NSAIDs-induced small bowel injury. J Gastroenterol 44:879\u2013888. https:\/\/doi.org\/10.1007\/s00535-009-0102-2","journal-title":"J Gastroenterol"},{"key":"2474_CR2","doi-asserted-by":"publisher","first-page":"378","DOI":"10.1007\/s00535-014-1028-x","volume":"50","author":"H Endo","year":"2015","unstructured":"Endo H, Sakai E, Kato T et al (2015) Small bowel injury in low-dose aspirin users. J Gastroenterol 50:378\u2013386. https:\/\/doi.org\/10.1007\/s00535-014-1028-x","journal-title":"J Gastroenterol"},{"key":"2474_CR3","doi-asserted-by":"publisher","first-page":"490","DOI":"10.1080\/00365520701794121","volume":"43","author":"T Matsumoto","year":"2008","unstructured":"Matsumoto T, Kudo T, Esaki M et al (2008) Prevalence of non-steroidal anti-inflammatory drug-induced enteropathy determined by double-balloon endoscopy: a Japanese multicenter study. Scand J Gastroenterol 43:490\u2013496. https:\/\/doi.org\/10.1080\/00365520701794121","journal-title":"Scand J Gastroenterol"},{"key":"2474_CR4","doi-asserted-by":"publisher","unstructured":"Edogawa S, Peters SA, Jenkins GD et al (2018) Sex differences in NSAID-induced perturbation of human intestinal barrier function and microbiota. FASEB J, fj201800560R. https:\/\/doi.org\/10.1096\/fj.201800560R","DOI":"10.1096\/fj.201800560R"},{"key":"2474_CR5","doi-asserted-by":"publisher","first-page":"500","DOI":"10.1053\/j.gastro.2017.10.049","volume":"154","author":"I Bjarnason","year":"2018","unstructured":"Bjarnason I, Scarpignato C, Holmgren E, Olszewski M, Rainsford KD, Lanas A (2018) Mechanisms of damage to the gastrointestinal tract from nonsteroidal anti-inflammatory drugs. Gastroenterology 154:500\u2013514. https:\/\/doi.org\/10.1053\/j.gastro.2017.10.049","journal-title":"Gastroenterology"},{"key":"2474_CR6","doi-asserted-by":"publisher","first-page":"809","DOI":"10.1016\/j.cgh.2015.10.022","volume":"14","author":"E Washio","year":"2016","unstructured":"Washio E, Esaki M, Maehata Y et al (2016) Proton pump inhibitors increase incidence of nonsteroidal anti-inflammatory drug-induced small bowel injury: A randomized, placebo-controlled trial. Clin Gastroenterol Hepatol 14:809-815.e801. https:\/\/doi.org\/10.1016\/j.cgh.2015.10.022","journal-title":"Clin Gastroenterol Hepatol"},{"issue":"1314\u20131322","key":"2474_CR7","doi-asserted-by":"publisher","first-page":"1322.e1311","DOI":"10.1053\/j.gastro.2011.06.075","volume":"141","author":"JL Wallace","year":"2011","unstructured":"Wallace JL, Syer S, Denou E et al (2011) Proton pump inhibitors exacerbate NSAID-induced small intestinal injury by inducing dysbiosis. Gastroenterology 141(1314\u20131322):1322.e1311\u20131315. https:\/\/doi.org\/10.1053\/j.gastro.2011.06.075","journal-title":"Gastroenterology"},{"key":"2474_CR8","doi-asserted-by":"publisher","first-page":"265","DOI":"10.1038\/nrmicro2538","volume":"9","author":"MA McGuckin","year":"2011","unstructured":"McGuckin MA, Lind\u00e9n SK, Sutton P, Florin TH (2011) Mucin dynamics and enteric pathogens. Nat Rev Microbiol 9:265\u2013278. https:\/\/doi.org\/10.1038\/nrmicro2538","journal-title":"Nat Rev Microbiol"},{"key":"2474_CR9","doi-asserted-by":"publisher","first-page":"463","DOI":"10.1038\/sj.bjp.0706889","volume":"149","author":"CL Hirota","year":"2006","unstructured":"Hirota CL, McKay DM (2006) Cholinergic regulation of epithelial ion transport in the mammalian intestine. Br J Pharmacol 149:463\u2013479. https:\/\/doi.org\/10.1038\/sj.bjp.0706889","journal-title":"Br J Pharmacol"},{"key":"2474_CR10","doi-asserted-by":"publisher","first-page":"G430","DOI":"10.1152\/ajpgi.00405.2011","volume":"302","author":"JK Gustafsson","year":"2012","unstructured":"Gustafsson JK, Ermund A, Johansson ME, Sch\u00fctte A, Hansson GC, Sj\u00f6vall H (2012) An ex vivo method for studying mucus formation, properties, and thickness in human colonic biopsies and mouse small and large intestinal explants. Am J Physiol Gastrointest Liver Physiol 302:G430-438. https:\/\/doi.org\/10.1152\/ajpgi.00405.2011","journal-title":"Am J Physiol Gastrointest Liver Physiol"},{"key":"2474_CR11","doi-asserted-by":"publisher","first-page":"611","DOI":"10.1038\/sj.bjp.0706923","volume":"149","author":"I Dey","year":"2006","unstructured":"Dey I, Lejeune M, Chadee K (2006) Prostaglandin E2 receptor distribution and function in the gastrointestinal tract. Br J Pharmacol 149:611\u2013623. https:\/\/doi.org\/10.1038\/sj.bjp.0706923","journal-title":"Br J Pharmacol"},{"key":"2474_CR12","doi-asserted-by":"publisher","first-page":"248","DOI":"10.1254\/jphs.10r06cr","volume":"114","author":"K Takeuchi","year":"2010","unstructured":"Takeuchi K, Kato S, Amagase K (2010) Prostaglandin EP receptors involved in modulating gastrointestinal mucosal integrity. J Pharmacol Sci 114:248\u2013261. https:\/\/doi.org\/10.1254\/jphs.10r06cr","journal-title":"J Pharmacol Sci"},{"key":"2474_CR13","doi-asserted-by":"publisher","first-page":"157","DOI":"10.1016\/s0928-4257(01)00021-3","volume":"95","author":"T Kunikata","year":"2001","unstructured":"Kunikata T, Araki H, Takeeda M, Kato S, Takeuchi K (2001) Prostaglandin E prevents indomethacin-induced gastric and intestinal damage through different EP receptor subtypes. J Physiol Paris 95:157\u2013163. https:\/\/doi.org\/10.1016\/s0928-4257(01)00021-3","journal-title":"J Physiol Paris"},{"key":"2474_CR14","doi-asserted-by":"publisher","first-page":"469","DOI":"10.1016\/S2468-1253(18)30119-5","volume":"3","author":"AS Taha","year":"2018","unstructured":"Taha AS, McCloskey C, McSkimming P, McConnachie A (2018) Misoprostol for small bowel ulcers in patients with obscure bleeding taking aspirin and non-steroidal anti-inflammatory drugs (MASTERS): a randomised, double-blind, placebo-controlled, phase 3 trial. Lancet Gastroenterol Hepatol 3:469\u2013476. https:\/\/doi.org\/10.1016\/S2468-1253(18)30119-5","journal-title":"Lancet Gastroenterol Hepatol"},{"key":"2474_CR15","doi-asserted-by":"publisher","first-page":"1279","DOI":"10.1016\/j.cgh.2008.06.021","volume":"6","author":"T Watanabe","year":"2008","unstructured":"Watanabe T, Sugimori S, Kameda N et al (2008) Small bowel injury by low-dose enteric-coated aspirin and treatment with misoprostol: a pilot study. Clin Gastroenterol Hepatol 6:1279\u20131282. https:\/\/doi.org\/10.1016\/j.cgh.2008.06.021","journal-title":"Clin Gastroenterol Hepatol"},{"key":"2474_CR16","doi-asserted-by":"publisher","first-page":"552","DOI":"10.1038\/nature10867","volume":"482","author":"AC Kruse","year":"2012","unstructured":"Kruse AC, Hu J, Pan AC et al (2012) Structure and dynamics of the M3 muscarinic acetylcholine receptor. Nature 482:552\u2013556. https:\/\/doi.org\/10.1038\/nature10867","journal-title":"Nature"},{"key":"2474_CR17","doi-asserted-by":"publisher","first-page":"439","DOI":"10.1007\/s10620-022-07637-y","volume":"68","author":"Y Igarashi-Hisayoshi","year":"2023","unstructured":"Igarashi-Hisayoshi Y, Ihara E, Bai X et al (2023) Determination of region-specific roles of the M3 muscarinic acetylcholine receptor in gastrointestinal motility. Dig Dis Sci 68:439\u2013450. https:\/\/doi.org\/10.1007\/s10620-022-07637-y","journal-title":"Dig Dis Sci"},{"key":"2474_CR18","doi-asserted-by":"publisher","first-page":"277","DOI":"10.1111\/bph.12599","volume":"172","author":"NT Burford","year":"2015","unstructured":"Burford NT, Traynor JR, Alt A (2015) Positive allosteric modulators of the \u03bc-opioid receptor: a novel approach for future pain medications. Br J Pharmacol 172:277\u2013286. https:\/\/doi.org\/10.1111\/bph.12599","journal-title":"Br J Pharmacol"},{"key":"2474_CR19","doi-asserted-by":"publisher","first-page":"2838","DOI":"10.3390\/ph3092838","volume":"3","author":"J Jakub\u00edk","year":"2010","unstructured":"Jakub\u00edk J, El-Fakahany EE (2010) Allosteric Modulation of muscarinic acetylcholine receptors. Pharmaceuticals (Basel) 3:2838\u20132860. https:\/\/doi.org\/10.3390\/ph3092838","journal-title":"Pharmaceuticals (Basel)"},{"key":"2474_CR20","doi-asserted-by":"publisher","first-page":"S160","DOI":"10.1016\/j.ijgo.2007.09.004","volume":"99","author":"OS Tang","year":"2007","unstructured":"Tang OS, Gemzell-Danielsson K, Ho PC (2007) Misoprostol: pharmacokinetic profiles, effects on the uterus and side-effects. Int J Gynaecol Obstet 99:S160-167. https:\/\/doi.org\/10.1016\/j.ijgo.2007.09.004","journal-title":"Int J Gynaecol Obstet"},{"key":"2474_CR21","doi-asserted-by":"publisher","first-page":"1153","DOI":"10.1139\/y06-068","volume":"84","author":"CL Hirota","year":"2006","unstructured":"Hirota CL, McKay DM (2006) M3 muscarinic receptor-deficient mice retain bethanechol-mediated intestinal ion transport and are more sensitive to colitis. Can J Physiol Pharmacol 84:1153\u20131161. https:\/\/doi.org\/10.1139\/y06-068","journal-title":"Can J Physiol Pharmacol"},{"key":"2474_CR22","doi-asserted-by":"publisher","first-page":"1403","DOI":"10.1007\/s00424-014-1595-y","volume":"467","author":"JK Gustafsson","year":"2015","unstructured":"Gustafsson JK, Lind\u00e9n SK, Alwan AH, Scholte BJ, Hansson GC, Sj\u00f6vall H (2015) Carbachol-induced colonic mucus formation requires transport via NKCC1, K\u207a channels and CFTR. Pflugers Arch 467:1403\u20131415. https:\/\/doi.org\/10.1007\/s00424-014-1595-y","journal-title":"Pflugers Arch"},{"key":"2474_CR23","doi-asserted-by":"publisher","first-page":"2613","DOI":"10.1172\/JCI38662","volume":"119","author":"MA Garcia","year":"2009","unstructured":"Garcia MA, Yang N, Quinton PM (2009) Normal mouse intestinal mucus release requires cystic fibrosis transmembrane regulator-dependent bicarbonate secretion. J Clin Invest 119:2613\u20132622. https:\/\/doi.org\/10.1172\/JCI38662","journal-title":"J Clin Invest"},{"key":"2474_CR24","doi-asserted-by":"publisher","first-page":"535","DOI":"10.1146\/annurev.physiol.62.1.535","volume":"62","author":"KE Barrett","year":"2000","unstructured":"Barrett KE, Keely SJ (2000) Chloride secretion by the intestinal epithelium: molecular basis and regulatory aspects. Annu Rev Physiol 62:535\u2013572. https:\/\/doi.org\/10.1146\/annurev.physiol.62.1.535","journal-title":"Annu Rev Physiol"},{"key":"2474_CR25","doi-asserted-by":"publisher","first-page":"425","DOI":"10.1016\/j.urology.2005.08.014","volume":"67","author":"M Yoshida","year":"2006","unstructured":"Yoshida M, Inadome A, Maeda Y et al (2006) Non-neuronal cholinergic system in human bladder urothelium. Urology 67:425\u2013430. https:\/\/doi.org\/10.1016\/j.urology.2005.08.014","journal-title":"Urology"},{"key":"2474_CR26","doi-asserted-by":"publisher","first-page":"51","DOI":"10.1016\/j.autneu.2018.05.009","volume":"213","author":"CS Pohl","year":"2018","unstructured":"Pohl CS, Lennon EM, Li Y, DeWilde MP, Moeser AJ (2018) S. Typhimurium challenge in juvenile pigs modulates the expression and localization of enteric cholinergic proteins and correlates with mucosal injury and inflammation. Auton Neurosci 213:51\u201359. https:\/\/doi.org\/10.1016\/j.autneu.2018.05.009","journal-title":"Auton Neurosci"},{"key":"2474_CR27","doi-asserted-by":"publisher","first-page":"1246","DOI":"10.1038\/sj.bjp.0701720","volume":"123","author":"L Spicuzza","year":"1998","unstructured":"Spicuzza L, Giembycz MA, Barnes PJ, Belvisi MG (1998) Prostaglandin E2 suppression of acetylcholine release from parasympathetic nerves innervating guinea-pig trachea by interacting with prostanoid receptors of the EP3-subtype. Br J Pharmacol 123:1246\u20131252. https:\/\/doi.org\/10.1038\/sj.bjp.0701720","journal-title":"Br J Pharmacol"},{"key":"2474_CR28","doi-asserted-by":"publisher","first-page":"33","DOI":"10.1016\/j.pharmthera.2008.04.006","volume":"119","author":"NM Nathanson","year":"2008","unstructured":"Nathanson NM (2008) Synthesis, trafficking, and localization of muscarinic acetylcholine receptors. Pharmacol Ther 119:33\u201343. https:\/\/doi.org\/10.1016\/j.pharmthera.2008.04.006","journal-title":"Pharmacol Ther"},{"key":"2474_CR29","doi-asserted-by":"publisher","first-page":"374","DOI":"10.1016\/j.neuropharm.2017.11.017","volume":"136","author":"D Zenko","year":"2018","unstructured":"Zenko D, Hislop JN (2018) Regulation and trafficking of muscarinic acetylcholine receptors. Neuropharmacology 136:374\u2013382. https:\/\/doi.org\/10.1016\/j.neuropharm.2017.11.017","journal-title":"Neuropharmacology"},{"key":"2474_CR30","doi-asserted-by":"publisher","first-page":"501","DOI":"10.1124\/jpet.107.120154","volume":"322","author":"H Liu","year":"2007","unstructured":"Liu H, Farley JM (2007) Prostaglandin E2 enhances acetylcholine-induced, Ca2+-dependent ionic currents in swine tracheal mucous gland cells. J Pharmacol Exp Ther 322:501\u2013513. https:\/\/doi.org\/10.1124\/jpet.107.120154","journal-title":"J Pharmacol Exp Ther"}],"container-title":["Journal of Molecular Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00109-024-02474-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s00109-024-02474-0\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00109-024-02474-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,8,28]],"date-time":"2024-08-28T23:43:58Z","timestamp":1724888638000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s00109-024-02474-0"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,8,22]]},"references-count":30,"journal-issue":{"issue":"9","published-print":{"date-parts":[[2024,9]]}},"alternative-id":["2474"],"URL":"https:\/\/doi.org\/10.1007\/s00109-024-02474-0","relation":{"has-preprint":[{"id-type":"doi","id":"10.21203\/rs.3.rs-3217047\/v1","asserted-by":"object"}]},"ISSN":["0946-2716","1432-1440"],"issn-type":[{"value":"0946-2716","type":"print"},{"value":"1432-1440","type":"electronic"}],"subject":[],"published":{"date-parts":[[2024,8,22]]},"assertion":[{"value":"30 July 2023","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"14 July 2024","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"31 July 2024","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"22 August 2024","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The ethics governing the use and conduct of experiments on animals were strictly observed, and the experimental protocol was approved by the Committee on Animal Research of Kyushu University (A19-263).","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethical approval"}},{"value":"YI and YT are the employees of Mochida Pharmaceutical Co., Ltd. whose company partly funded this study. EI belongs to an endowed course supported by companies including Ono Pharmaceutical Co., Ltd., Miyarisan Pharmaceutical Co., Ltd., Sanwa Kagaku Kenkyusho Co., Ltd., Otsuka Pharmaceutical Factory, Inc., Fujifilm Medical Co., Ltd., Terumo Corporation, FANCL Corporation, Ohga Pharmacy, and Abbott Japan, LLC. EI receives a lecture honorarium from Takeda Pharmaceutical Company. YO conducts collaborative research with Fujifilm Medical Co., Ltd. and FANCL Corporation.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Disclosures"}}]}}